Endogenous nitric oxide modulates myocardial oxygen consumption in canine right ventricle

Srinath Setty, Xiaoming Bian, Johnathan Tune, H. Fred Downey

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The role of endogenous nitric oxide (NO) in modulating myocardial oxygen consumption (MV̇O2) is unclear, in part because of systemic and coronary hemodynamic effects of blocking NO release. This study evaluated the effect of NO on right ventricular MV̇O2 under controlled hemodynamic conditions. In 12 open-chest dogs, Nω-nitro-L-arginine methyl ester (L-NAME, 150 μg/min), a NO synthase (NOS) blocker, was infused into the right coronary artery. Heart rate and mean aortic pressure were constant. Right coronary blood flow and right ventricular MV̇O2 were measured at normal and elevated right coronary perfusion pressures (RCP) before and after L-NAME. To avoid effects of NO synthesis blockade on right coronary blood flow, which might have altered right ventricular MV̇O2, experiments, were conducted during adenosine-induced maximal coronary vasodilation. L-NAME did not affect right coronary blood flow (P = 0.51). However, L-NAME significantly increased right ventricular MV̇O2 (6% at RCP 100 mmHg, and 21% at RCP 180 mmHg). Right coronary blood flow varied with perfusion pressure (P <0.02), and the elevation of MV̇O2 produced by L-NAME increased at higher flows (P <0.04), consistent with the greater shear stress-mediated release of NO. These findings indicate that endogenous NO limits right ventricular MV̇O2.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume281
Issue number2 50-2
StatePublished - 2001
Externally publishedYes

Fingerprint

Oxygen Consumption
NG-Nitroarginine Methyl Ester
Heart Ventricles
Canidae
Nitric Oxide
Perfusion
Pressure
Hemodynamics
Vasodilation
Nitric Oxide Synthase
Adenosine
Coronary Vessels
Arterial Pressure
Thorax
Heart Rate
Dogs

Keywords

  • Maximal vasodilation
  • N-nitro-L-arginine methyl ester
  • Open-chest dogs
  • Right coronary blood flow
  • Right coronary perfusion pressure

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Endogenous nitric oxide modulates myocardial oxygen consumption in canine right ventricle. / Setty, Srinath; Bian, Xiaoming; Tune, Johnathan; Downey, H. Fred.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 281, No. 2 50-2, 2001.

Research output: Contribution to journalArticle

@article{ecc351b842de472f843516041fa2fc62,
title = "Endogenous nitric oxide modulates myocardial oxygen consumption in canine right ventricle",
abstract = "The role of endogenous nitric oxide (NO) in modulating myocardial oxygen consumption (MV̇O2) is unclear, in part because of systemic and coronary hemodynamic effects of blocking NO release. This study evaluated the effect of NO on right ventricular MV̇O2 under controlled hemodynamic conditions. In 12 open-chest dogs, Nω-nitro-L-arginine methyl ester (L-NAME, 150 μg/min), a NO synthase (NOS) blocker, was infused into the right coronary artery. Heart rate and mean aortic pressure were constant. Right coronary blood flow and right ventricular MV̇O2 were measured at normal and elevated right coronary perfusion pressures (RCP) before and after L-NAME. To avoid effects of NO synthesis blockade on right coronary blood flow, which might have altered right ventricular MV̇O2, experiments, were conducted during adenosine-induced maximal coronary vasodilation. L-NAME did not affect right coronary blood flow (P = 0.51). However, L-NAME significantly increased right ventricular MV̇O2 (6{\%} at RCP 100 mmHg, and 21{\%} at RCP 180 mmHg). Right coronary blood flow varied with perfusion pressure (P <0.02), and the elevation of MV̇O2 produced by L-NAME increased at higher flows (P <0.04), consistent with the greater shear stress-mediated release of NO. These findings indicate that endogenous NO limits right ventricular MV̇O2.",
keywords = "Maximal vasodilation, N-nitro-L-arginine methyl ester, Open-chest dogs, Right coronary blood flow, Right coronary perfusion pressure",
author = "Srinath Setty and Xiaoming Bian and Johnathan Tune and Downey, {H. Fred}",
year = "2001",
language = "English (US)",
volume = "281",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "2 50-2",

}

TY - JOUR

T1 - Endogenous nitric oxide modulates myocardial oxygen consumption in canine right ventricle

AU - Setty, Srinath

AU - Bian, Xiaoming

AU - Tune, Johnathan

AU - Downey, H. Fred

PY - 2001

Y1 - 2001

N2 - The role of endogenous nitric oxide (NO) in modulating myocardial oxygen consumption (MV̇O2) is unclear, in part because of systemic and coronary hemodynamic effects of blocking NO release. This study evaluated the effect of NO on right ventricular MV̇O2 under controlled hemodynamic conditions. In 12 open-chest dogs, Nω-nitro-L-arginine methyl ester (L-NAME, 150 μg/min), a NO synthase (NOS) blocker, was infused into the right coronary artery. Heart rate and mean aortic pressure were constant. Right coronary blood flow and right ventricular MV̇O2 were measured at normal and elevated right coronary perfusion pressures (RCP) before and after L-NAME. To avoid effects of NO synthesis blockade on right coronary blood flow, which might have altered right ventricular MV̇O2, experiments, were conducted during adenosine-induced maximal coronary vasodilation. L-NAME did not affect right coronary blood flow (P = 0.51). However, L-NAME significantly increased right ventricular MV̇O2 (6% at RCP 100 mmHg, and 21% at RCP 180 mmHg). Right coronary blood flow varied with perfusion pressure (P <0.02), and the elevation of MV̇O2 produced by L-NAME increased at higher flows (P <0.04), consistent with the greater shear stress-mediated release of NO. These findings indicate that endogenous NO limits right ventricular MV̇O2.

AB - The role of endogenous nitric oxide (NO) in modulating myocardial oxygen consumption (MV̇O2) is unclear, in part because of systemic and coronary hemodynamic effects of blocking NO release. This study evaluated the effect of NO on right ventricular MV̇O2 under controlled hemodynamic conditions. In 12 open-chest dogs, Nω-nitro-L-arginine methyl ester (L-NAME, 150 μg/min), a NO synthase (NOS) blocker, was infused into the right coronary artery. Heart rate and mean aortic pressure were constant. Right coronary blood flow and right ventricular MV̇O2 were measured at normal and elevated right coronary perfusion pressures (RCP) before and after L-NAME. To avoid effects of NO synthesis blockade on right coronary blood flow, which might have altered right ventricular MV̇O2, experiments, were conducted during adenosine-induced maximal coronary vasodilation. L-NAME did not affect right coronary blood flow (P = 0.51). However, L-NAME significantly increased right ventricular MV̇O2 (6% at RCP 100 mmHg, and 21% at RCP 180 mmHg). Right coronary blood flow varied with perfusion pressure (P <0.02), and the elevation of MV̇O2 produced by L-NAME increased at higher flows (P <0.04), consistent with the greater shear stress-mediated release of NO. These findings indicate that endogenous NO limits right ventricular MV̇O2.

KW - Maximal vasodilation

KW - N-nitro-L-arginine methyl ester

KW - Open-chest dogs

KW - Right coronary blood flow

KW - Right coronary perfusion pressure

UR - http://www.scopus.com/inward/record.url?scp=0034885029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034885029&partnerID=8YFLogxK

M3 - Article

C2 - 11454588

AN - SCOPUS:0034885029

VL - 281

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 2 50-2

ER -